Skip to main navigation
Logo

Investors

Press Releases

Press Releases

  • All
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2016
April 27, 2022
Adicet Bio Announces Oral Presentation of Updated ADI-001 Phase 1 Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
April 19, 2022
Adicet Bio Receives FDA Fast Track Designation for Lead Candidate ADI-001
April 7, 2022
Adicet Bio to Participate in Upcoming Investor Conferences
April 1, 2022
Adicet Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 15, 2022
Adicet Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress
March 4, 2022
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
February 2, 2022
Adicet Bio to Participate in Guggenheim 2022 Oncology Conference
December 10, 2021
Adicet Bio, Inc. Announces Closing of $100 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
December 8, 2021
Adicet Bio, Inc. Announces Pricing of Public Offering of Common Stock
December 7, 2021
Adicet Bio, Inc. Announces Proposed Follow-On Offering of Common Stock

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Current page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • …
  • Next page next ›
  • Last page last »
Displaying 101 - 110 of 163

Tools

  • Print
    Print
  • Email Alerts
    Email Alerts
  • Investor Contacts
    Investor Contacts

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
  • Stock Information
  • Corporate Governance
  • Financial Information
  • Investor Resources

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
    • Stock Quote & Chart
    • Analyst Coverage
    • Governance Highlights
    • Leadership and Board of Directiors
  • Financial Information
    • Investor FAQs
    • Information Request
    • Email Alerts
    • Investor Contacts

Adicet - Header Navigation

  • About
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Gamma Delta T Cells
    • Targeting Moieties
    • Proprietary Cell Platform
  • Pipeline
    • Pipeline
    • Expanded Access Policy
    • Presentations and Publications
  • Investors
    • Overview
    • Press Releases
    • Presentations & Events
    • Stock Information
    • Corporate Governance
    • Financial Information
    • Investor Resources
  • Careers
    • Join Our Team
    • Current Openings
  • Contact

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Governance Highlights
    • Leadership and Board of Directiors
  • Financial Information
  • Investor Resources
    • Investor FAQs
    • Information Request
    • Email Alerts
    • Investor Contacts
Logo © 2024 Adicet Bio All rights reserved. Website Design: Hane Chow, Inc.